SEC Form 4 · accession 0001615774-16-005013
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernd Metzner
Director
Period of report
Apr 2, 2015
Accepted (ET)
Apr 18, 2016 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $0.92 | Apr 2, 2015 | A | 50,000 | A | — | Apr 2, 2025 | Common Stock | 50,000 | 87,500 | D |
Explanation of responses
- F1On October 7, 2015, the Issuer effected a reverse stock split at a ratio of 1 to 4. The numbers herein are shown on post-split basis
- F2Represents stock option granted under Issuer's 2007 Stock Option Plan to vest in three equal installments on April 2, 2015, April 2, 2016 and April 2, 2017